Observational study registries covering the Dermogenix compound class — the proprietary bioregulator series underlying HelioMystique protocols — have been indexed on VerifiedEnroll, the precision oncology and clinical data infrastructure platform. The registries document compound exposure history, biomarker profiles, and longitudinal outcomes across multiple skin tissue applications. Indexing on VerifiedEnroll establishes a structured evidence pathway for the Dermogenix compound class that is accessible to researchers, clinicians, and institutional partners.